Navigation Links
Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results
Date:5/17/2010

tain our previous levels of profitability including on account of our ability to manage growth, intense competition, wage increases in China, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, our ability to successfully complete and integrate potential acquisitions, withdrawal of governmental fiscal incentives, political instability and regional conflicts and legal restrictions on raising capital or acquiring companies outside China. Additional risks that could affect our future operating results are more fully described in our United States Securities and Exchange Commission filings including our S-1 dated June 27, 2008, our Quarterly Report on Form 10-Q for the quarter ended September 30, 2009, our 10-K for the year ended December 31, 2008, and other recent filings. These filings are available at http://www.sec.gov . We may, from time to time, make additional written and oral forward-looking statements, including statements contained in our filings with the Securities and Exchange Commission and our reports to shareholders. We do not undertake to update any forward-looking statements that may be made from time to time by or on our behalf.

About Non-GAAP Financial Measures

To supplement the Company's consolidated financial statements, which statements are prepared and presented in accordance with GAAP, we use the following non-GAAP financial measures: non-GAAP adjusted net income, and non- GAAP adjusted EPS. The presentation of this financial information is not intended to be considered in isolati
'/>"/>

SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Biostar Pharmaceuticals, Inc. to Launch Xin Aoxing Oleanolic Acid Capsules in Beijing and Shanghai
2. Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
3. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
4. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
5. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
6. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
7. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
8. Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.
9. Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2009
10. Poniard Pharmaceuticals, Inc. to Present Additional Cancer Treatment Data Found Significant by TapeBeat.Com Investors
11. Lotus Pharmaceuticals, Inc. Appoints OTC Division Head
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015   Y-Prime, Inc ... the BIO Exhibition 2015 in Philadelphia ... world,s largest biotechnology gathering, allows influential decision makers ... where they can evaluate emerging technologies such as ... expertise in the design, implementation and management of ...
(Date:6/2/2015)... 2015   Intrexon Corporation (NYSE: ... today the appointment of Olivier R. Jarry ... Mr. Jarry will lead the expansion of Intrexon,s programs ... for consumer markets.  Mr. Jarry ... in leading global life sciences and consumer health ...
(Date:6/2/2015)... KONG , June 2, 2015 /PRNewswire/ -- China Cord Blood ... and "our"), China,s leading provider of ... stem cell storage services, today announced that the Special Committee ... appointed Houlihan Lokey ( China ) ... & Hamilton LLP as its United States ...
(Date:6/2/2015)... 02, 2015 Through rare discovery of ... Yancy Corporation is enabling World Scientists to actually ... biological sample, displaying the full nature (position, shape, size, ... , Jeff Porter, Co-Founder of the Yancy Corporation, says, ... – rare. They come once in a lifetime, if ...
Breaking Biology Technology:YPrime at BIO Exhibition in Philadelphia and DIA in Washington DC during the month of June 2Intrexon Announces New Sector Leader 2Intrexon Announces New Sector Leader 3China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 3Scientists Eying Rare Discovery Of New Physics & Light Microscope Technology 2
... March 9 Cynvec LLC, a privately held biotechnology ... the apoptotic ability of the sindbis viral vector, today ... will present at the Cowen and Company 29th Annual ... 2009 at 4:00 p.m. ET. About Cynvec ...
... DIEGO, March 9 PURE Bioscience (Nasdaq: ... dihydrogen citrate (SDC) antimicrobial, today announced that John ... Board of Directors. Dr. Carbone fills the ... on February 13, 2009.(Logo: http://www.newscom.com/cgi-bin/prnh/20060119/LATH060LOGO )Michael ...
... Spectral Diagnostics Inc. (TSX:SDI) today announced that it ... Inc. of Japan granting Spectral the exclusive development ... a therapeutic device for the treatment of sepsis ... terms of the agreement, Spectral will seek FDA ...
Cached Biology Technology:PURE Bioscience Board Appoints John J. Carbone, MD to Board of Directors 2PURE Bioscience Board Appoints John J. Carbone, MD to Board of Directors 3PURE Bioscience Board Appoints John J. Carbone, MD to Board of Directors 4Spectral signs exclusive license agreement to bring sepsis therapeutic to the U.S. market 2Spectral signs exclusive license agreement to bring sepsis therapeutic to the U.S. market 3
(Date:5/14/2015)... , May 14, 2015  Verificient Technologies, ... verification and online remote proctoring, announced a ... (SaaS) company and creator of the Canvas ... the two companies will benefit from the ... As a fully integrated multifactor ...
(Date:5/8/2015)... , May 8, 2015 Synaptics Inc. (NASDAQ: ... announced that members of the executive management team will present ... Annual Technology, Media and Telecom Conference Date: May 18, ... Boston, MA Cowen and ... Time: 2:45pm ET Location: The New York Palace Hotel, ...
(Date:4/27/2015)... Apr. 27, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... pre-order customers the first week of May, 2015 and ... of May. Gino Pereira , ... for the company as Wocket® enters the consumer market. ...
Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Synaptics to Present at Upcoming Investor Conferences 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3
... The research could eventually lead to new approaches for ... livestock which are caused by trypanosomes carried by the ... sexual reproduction evolved very early and is now ubiquitous ... all living organisms except bacteria). However, real evidence ...
... PITTSBURGHKrzysztof Matyjaszewski, the J.C. Warner Professor of the Natural Sciences ... named a recipient of the 2011 Wolf Prize in Chemistry ... given every year in four out of five categories, in ... 262 scientists from around the world have been honored with ...
... Ensuring the sustainability of the products we use is ... more important for consumers and companies. A researcher from ... up with an eco-labelling system that provides environmental information, ... services in question during their "life cycle". ...
Cached Biology News:Shining a light on trypanosome reproduction 2Carnegie Mellon's Matyjaszewski to receive Wolf Prize in Chemistry 2Carnegie Mellon's Matyjaszewski to receive Wolf Prize in Chemistry 3Choose less contaminating products thanks to eco-labeling 2
Includes a choice of any 3 EasySep mouse selection kits and EasySep magnet...
... stabilizing 1.5mg of purified RNA samples., , ... stabilization of aqueous RNA samples that have ... guanidine, phenol/chloroform, silica, oligo dT etc or ... all the necessary components for the stabilization ...
Human SEAP ORF, provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
...
Biology Products: